ALL_20255 Faculty MD Codes Key Card

AM

AMI Leaders What is the objective of the AMI Leaders programme?

Produced and funded by Allergan.

ND/0247/2019 | Date of preparation: July 2019

AMI Leaders

Learn a new language and injection methodology with an introduction to the MD Codes™ and their clinical applications

AMI Leaders

AM

AMI Leaders

What is the purpose of the MD Codes™?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

AMI Leaders

To support the technical development of injectors

AMI Leaders

AM

AMI Leaders

What are the MD Codes™?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

AMI Leaders A specific language in facial aesthetics to raise awareness that each aesthetic facial unit (e.g. cheek, chin, lips) comprises subunits that must be respected during injection

AMI Leaders

AM

AMI Leaders

What does FACT stand for?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

AMI Leaders

Finance Assessment Communication Technique AMI Leaders

AM

AMI Leaders

F is for Finance

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

AMI Leaders The MD Codes™ help patients to see more clearly the different components of their treatment plan and make informed decisions

AMI Leaders

AM

AMI Leaders

A is for Assessment

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

AMI Leaders By understanding how facial units and subunits impact each other, correct diagnosis can be made and appropriate treatments identified

AMI Leaders

AM

AMI Leaders

C is for Communication

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

AMI Leaders Patient wants and patient needs are often misaligned The MD Codes™ can help educate patients on their treatment needs

AMI Leaders

AM

AMI Leaders

T is for Technique

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

AMI Leaders The MD Codes™ provide in-depth guidance on appropriate injection technique

AMI Leaders

AM

AMI Leaders

What is the concept of patient wants versus patient needs?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

AMI Leaders Patient wants (their treatment requests) and patient needs (their clinical diagnosis) often differ An expert injector should educate their patient on the treatment that will aim to provide the best clinical outcome

AMI Leaders

AM

AMI Leaders

What is the concept of Foundation– Contour–Refinement?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

AMI Leaders The recommended order in which treatment with the MD Codes™ should be considered, to revitalise the face in an architectural mode

AMI Leaders

BUILD FOUNDATION Midface

Ck

Ck

Produced and funded b

Question goes here...

For illustrative purposes only Produced and funded by Allergan. Image Š owned by Allergan Funded byINT/0712/2018ab Allergan | INT/0712/2018ab | Date of preparation: March 2019 | Date of preparation: March 2019

AM

AMI Leaders As with building a house, facial aesthetic treatment should begin with the foundation – creating structure to support the overlying tissues

AMI Leaders

CREATE CONTOUR Upper and lower face

T

T

Question goes here...

Jw

Jw C For illustrative purposes only

Produced and funded by Allergan. Image Š owned by Allergan Funded byINT/0712/2018ab Allergan | INT/0712/2018ab | Date of preparation: March 2019 | Date of preparation: March 2019

AM

AMI Leaders

Once the foundation is in place, treatment should focus on shaping the contours of the upper and/or lower face

AMI Leaders

FOCUS ON REFINEMENT

Upper and lower face F

E

E

Tt

Tt

O

O

NL

NL

Question goes here...

Lp

M

M

For illustrative purposes only Produced and funded by Allergan. Image © owned by Allergan Funded byINT/0712/2018ab Allergan | INT/0712/2018ab | Date of preparation: March 2019 | Date of preparation: March 2019

AM

AMI Leaders Any remaining refinements, such as lines or folds, should be addressed after the first two stages have been completed, as their appearance may have already improved

AMI Leaders

F2

F1

F3

F1

G1

F2

G1 G2

Tt2

Tt3 Tt1

Lp7

Lp

Lp8

Lp 2

3

Lp

Lp 6

Lp11

Lp4

Lp1

Lp1 Lp5

3

Lp11

Lp5

C1

C6

C6

C3

C5

C3 C4

C5

C2

For illustrative purposes only Produced and funded by Allergan. Image © owned by Allergan Funded byINT/0712/2018ab Allergan | INT/0712/2018ab | Date of preparation: March 2019 | Date of preparation: March 2019

T2

E2 E3 E1

T1

O3

O1

O2

Ck1

Ck2

Ck3

Jw2 Ck4 NL 1

Ck5 2

NL 3

NL

Jw1

M1 M2

3 Jw

M3

Jw5

Jw4

For illustrative purposes only Produced and funded by Allergan. Image Š owned by Allergan Funded byINT/0712/2018ab Allergan | INT/0712/2018ab | Date of preparation: March 2019 | Date of preparation: March 2019

Starting the journey

Starting the journey

Produced and funded by Allergan. Image Š owned by Allergan and Dr Mauricio de Maio | INT/0712/2018ab | Date of preparation: March 2019

P

1

AM

P A T T E R N S .

P A T T E R N S .

1

P

AMI Leaders

Systematise the basics There are patterns and sequences to facial revitalisation

AMI Leaders

V

AMI Visionary What are the objectives of the AMI Visionary programme?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Visionary Explore a new approach to patient consultation with the emotional attributes Learn how to treat key facial signs with the MD Codes™ Equations

Visionary

V

AMI Visionary What is the purpose of the emotional attributes (patient feels)?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Visionary To help injectors understand patients’ real motivations for seeking treatment and deliver an outcome that meets their true expectations

Visionary

V

AMI Visionary

What are the positive emotional attributes?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Visionary

THE DREAM

The overall facial messages patients often aspire to: Look more attractive Look younger Look slimmer/more contoured Look more feminine/masculine

Visionary

V

AMI Visionary

What are the negative emotional attributes?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Visionary THE REALITY The overall facial messages that detract from facial attractiveness and youthfulness Look less tired Look less sad Look less saggy

Visionary

Look less angry

V

AMI Visionary

What does ‘clean the house first’ mean?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Visionary

To achieve the positive emotional attributes, negative messages should first be reduced or erased

Visionary

V

AMI Visionary

What are key facial signs?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Visionary A suboptimal feature or ageing sign (e.g. a saggy cheek) that is characteristic of a negative emotional attribute

Visionary

V

AMI Visionary

What are the MD Codesâ„¢ Equations?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Visionary The translation of the key facial signs into the MD Codes™ A step towards creating the MD Codes™ Formulas

Visionary

Shifting mindset

Shifting mindset

Produced and funded by Allergan. Image Š owned by Allergan and Dr Mauricio de Maio | INT/0712/2018ab | Date of preparation: March 2019

P

2

V

P A R A D I G M .

P A R A D I G M .

2

P

Visionary Place a value on expertise Patients expect more than what they ask for

Visionary

D

AMI Distinction What are the objectives of the AMI Distinction programme?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Distinction Bring strategy to treatment planning with the MD Codes™ Formulas Learn a system to organise the facial assessment process with MD ASA™

Distinction

D

AMI Distinction

What does MD ASA™ stand for and what is its purpose?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Distinction Multi-Dimensional Aesthetic Scan Assessment A system of aesthetic hierarchy to organise the patient assessment process and train the brain to decipher complex and unveiled signs of the face

Distinction

D

AMI Distinction

What is the aesthetic hierarchy?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Distinction

The five pillars of systematic facial assessment, ranging from full face (H1) to distractions (H5)

Distinction

D

AMI Distinction

What are the MD Codes™ Formulas?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Distinction A sequence of MD Codes™ Equations that, when grouped together, form a holistic treatment plan that aims to address a specific emotional attribute

Distinction

D

AMI Distinction

What is the MD Codes™ Formulas Treatment Plan?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Th ses sh inj pa be pe

Distinction A multi-session treatment planning strategy that uses volume estimations to deliver the MD Codes™ Formulas, tailored to individual patient needs

Distinction This approach generally recommends that each session is built around four syringes; however, this should be based on the clinical judgement of the injector. This volume may not be suitable for all patients for all sessions. Clinical judgment should be used to determine the total volume appropriate per session, based on individual patient needs.

MD ASA™ aesthetic hierarchy

Distinction

Produced and funded by Allergan. Image Š owned by Allergan and Dr Mauricio de Maio | INT/0712/2018ab | Date of preparation: March 2019

H1: Full face: Analysis Patient feels: Emotional attributes

H2: Facial thirds and neck: Analysis Patient presents: Symmetry and proportion

Distinction

H3: Periorbital and perioral: Analysis Patient expresses: Animation

H4: Facial units: Analysis Patient needs: Key facial units or areas

H5: Facial subunits: Analysis Patient wants: Distractions Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Establishing priorities

Establishing priorities

Produced and funded by Allergan. Image Š owned by Allergan and Dr Mauricio de Maio | INT/0712/2018ab | Date of preparation: March 2019

P

3

D

P L A N N I N G .

P L A N N I N G .

3

P

Distinction Plan according to outcomes Patients expect more than what they ask for

Distinction

Ex AMI Expression What are the objectives of the AMI Expression programme?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Expression Explore the principles of dynamic ageing and dynamic beauty with the introduction of the MD DYNA Codes™ and dynamic MD ASA™

Expression

Ex AMI Expression

What is dynamic beauty?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

1. d

Expression

Beauty is not only related to the face at rest; it requires co-ordination of multiple mimetic muscles1 Facial treatments should aim to produce a balanced and harmonious outcome both at rest and on animation

Expression

1. de Maio M. Aesthetic Plast Surg 2018; 42:798–814.

Ex AMI Expression

What is dynamic ageing?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

1. d

Expression Dynamic ageing is the muscle imbalance that happens during the ageing process, caused by loss of structural support and the gravitational impact on facial areas1

Expression 1. de Maio M. Aesthetic Plast Surg 2018; 42:798–814.

Ex AMI Expression

What is the concept of patient expresses?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Expression There may be ageing signs and/or downgrading features that only appear on animation and these should be identified during facial assessment to avoid unnatural results

Expression

Ex AMI Expression

What is the principle of chemical myomodulation?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

*Bo and Ind req info

1. d

Expression It is the chemical* approach to reduce dynamic lines through intramuscular injection1

Expression *Botulinum toxin type A indications may vary by country and responses to treatment may differ between patients.

Indication requirements will be dependent on patient requirements. Please refer to your local prescribing information for full product information and indications.

1. de Maio M. Aesthetic Plast Surg 2018; 42:798–814.

Ex AMI Expression

What is the principle of mechanical myomodulation?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

1. d

Expression It is the principle that mimetic muscles can be affected by the precise placement of hyaluronic acid filler below or above the fibres to either facilitate or reduce muscle action, respectively1

Expression 1. de Maio M. Aesthetic Plast Surg 2018; 42:798–814.

Ex AMI Expression

What are the MD DYNA Codesâ„¢?

Produced and funded by Allergan.

INT/0712/2018ab | Date of preparation: March 2019

Expression Precise injection techniques to indirectly modulate muscle activity and help injectors deliver natural facial expression and aesthetic rehabilitation of the face

Expression

Periorbital muscles1

Expression F

F

C

C P

OOc

OOc

Produced and funded by Allergan. Image Š owned by Allergan INT/0712/2018ab | Date of preparation: March 2019

Perioral muscles1

Expression N

* LAO

N

DSN

LAN

LLS

ZMi R

ZMj

OO

OO

DAO

DLI

* Deep to upper lip levators

PL

M

B*

Image © owned by Allergan | 1. Gray H. The muscles and fasciae.

In: Pick TP, Howden R, eds. Anatomy, Descriptive and Surgical.

1st ed. Running Press, 1974. p. 306–15. ISBN: 978-0-7020-5230-9.

Anticipating challenges

Anticipating challenges

Produced and funded by Allergan. Image Š owned by Allergan and Dr Mauricio de Maio | INT/0712/2018ab | Date of preparation: March 2019

P

4

Ex P R E D I C T I O N .

P R E D I C T I O N .

4

P

Expression Learn from facial animation Dynamic ageing can predict static ageing

Expression